Review
Accepted on 11 Dec 2025
Advances in pulmonary neuroendocrine cells and their cellular interactions in asthma pathogenesis
in Inflammation Pharmacology
Frontiers in Pharmacology
Type at least 3 characters
1,823 articles
Original Research
Published on 10 Dec 2025
Isoliensinine confers neuroprotection and alleviates LPS-induced neuroinflammation in microglia by regulating the MAPK/NF-κB signaling
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1675865
- 241 views
Review
Published on 10 Dec 2025
Immune modulation in inflammatory bowel disease: therapeutic promise of baicalein
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1723606
- 222 views
Review
Accepted on 09 Dec 2025
Molecular insights into NLRP3 inflammasome and miRNA modulation in oral cancer
in Inflammation Pharmacology
Frontiers in Pharmacology
- 174 views
Review
Accepted on 08 Dec 2025
Cycloastragenol in Inflammation-Related Diseases: Mechanisms, Pharmacokinetics, and Translational Prospects
in Inflammation Pharmacology
Frontiers in Pharmacology
Original Research
Accepted on 04 Dec 2025
Inflammatory Response in CF Airway Epithelial Cells: A Comparative Study of Modulators and Wild-Type CFTR Rescue
in Inflammation Pharmacology
Frontiers in Pharmacology
Systematic Review
Published on 04 Dec 2025
Effectiveness and safety of tocilizumab in refractory noninfectious uveitis: a systematic review and meta-analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1694311
- 454 views
Mini Review
Published on 04 Dec 2025
CX3CR1: a potential microglia-specific PET imaging target in Alzheimer’s and Parkinson’s diseases
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1678159
- 335 views
Review
Published on 03 Dec 2025
Dapansutrile in multidisciplinary therapeutic applications: mechanisms and clinical perspectives
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1731165
- 409 views
Original Research
Published on 03 Dec 2025
The clinical value of PLR, NLR, and MLR in predicting mortality risk in hospitalized patients
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1736947
- 491 views
Original Research
Accepted on 02 Dec 2025
Neoantigen immune responses in healthy volunteers: insights from multiple integrated keyhole limpet hemocyanin challenge studies on repeated immunization and response covariates
in Inflammation Pharmacology
Frontiers in Pharmacology
Opinion
Published on 02 Dec 2025
CCR5-targeted γδ CAR-T cells: a rational step toward HIV-resistant allogeneic immunotherapy
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1734423
- 356 views
Original Research
Published on 01 Dec 2025
Acetyl-11-keto-beta-boswellic acid ameliorates monosodium iodoacetate-induced osteoarthritis in rats: implications of HMGB1/TLR4/NF-κB and Nrf2/HO-1
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1694803
- 524 views
Review
Accepted on 30 Nov 2025
Flavonoids in inflammatory bowel disease: Multi-dimensional mechanisms via modulation of the intestinal barrier-microbiota-immune axis
in Inflammation Pharmacology
Frontiers in Pharmacology
Original Research
Accepted on 28 Nov 2025
Oleanolic Acid Cubic Liquid Crystal Nanoparticle-Based Thermosensitive Gel Attenuates Knee Osteoarthritis Symptoms in Rats
in Inflammation Pharmacology
Frontiers in Pharmacology
Original Research
Published on 28 Nov 2025
Omega 3 fatty acid docosahexaenoic acid (DHA) mitigates inflammatory responses in experimental sepsis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1708348
- 786 views